Two new studies from the Indiana University School of Medicine are offering a clearer picture of Alzheimer’s disease — both how it changes the brain and what early screening means for caregivers.

Blood-based biomarkers, such as Roche’s pTau181 test, offer a powerful tool for identifying the right patients for Alzheimer’s disease clinical trials early. This October saw a landmark development in ...

Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, ...

A man from the world’s largest known Alzheimer’s family should have lost his memory by his late 40s. Every other carrier of ...

When words fade due to dementia, talking to the people you love becomes more difficult. Fortunately, support is available.

Please provide your email address to receive an email when new articles are posted on . Integrating cognitive screenings into well visits can help identify dementia in its early symptomatic stages.

Research reveals why Alzheimer’s brain damage doesn’t always lead to dementia, highlighting the role of protective brain ...

Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers found that up to nine in ten cases could be linked to the APOE gene — even ...

Millions of Americans support loved ones with dementia. While dementia caregiving can be rewarding, it can also be challenging — particularly if your loved one presents with signs of dementia .

Have you ever wondered how an Alzheimer’s patient literally views the world and what they experience in the confusion? Now, families and caregivers can have the experience through special goggles ...